Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal

[1]  N. Petrosillo,et al.  Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future , 2019, Journal of clinical medicine.

[2]  Stephan Weise,et al.  Present and Future , 2019, A Fossil History of Southern African Land Mammals.

[3]  J. Otlewski,et al.  Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment , 2018, Journal of clinical medicine.

[4]  E. Peterson,et al.  Antibiotic Resistance Mechanisms in Bacteria: Relationships Between Resistance Determinants of Antibiotic Producers, Environmental Bacteria, and Clinical Pathogens , 2018, Front. Microbiol..

[5]  L. Riemann,et al.  Diazotrophs and N2-Fixation Associated With Particles in Coastal Estuarine Waters , 2018, Front. Microbiol..

[6]  K. Kazmierczak,et al.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015 , 2018, Antimicrobial Agents and Chemotherapy.

[7]  D. Paterson,et al.  Treatment of Infections by OXA-48-Producing Enterobacteriaceae , 2018, Antimicrobial Agents and Chemotherapy.

[8]  S. Octavia,et al.  Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae , 2018, Antimicrobial Agents and Chemotherapy.

[9]  P. Nordmann,et al.  Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae , 2018, The Journal of antimicrobial chemotherapy.

[10]  M. Castanheira,et al.  1686. Antimicrobial Activity of Aztreonam-avibactam, Ceftazidime-Avibactam, and Comparator Agents against Pseudomonas aeruginosa from Cystic Fibrosis Patients , 2017, Open Forum Infectious Diseases.

[11]  R. Humphries,et al.  Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs , 2016, Journal of Clinical Microbiology.

[12]  Tse Hsien Koh,et al.  In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli , 2015, Antimicrobial Agents and Chemotherapy.

[13]  S. Pournaras,et al.  Evaluation of a New Phenotypic OXA-48 Disk Test for Differentiation of OXA-48 Carbapenemase-Producing Enterobacteriaceae Clinical Isolates , 2015, Journal of Clinical Microbiology.

[14]  J. Hrabák,et al.  Detection of OXA-48-type carbapenemase-producing Enterobacteriaceae in diagnostic laboratories can be enhanced by addition of bicarbonates to cultivation media or reaction buffers , 2014, Folia Microbiologica.

[15]  Clsi.  Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .

[16]  R. Bonomo,et al.  Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.

[17]  G. Jacoby,et al.  Updated Functional Classification of β-Lactamases , 2009, Antimicrobial Agents and Chemotherapy.

[18]  P. Nordmann,et al.  Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey , 2008, Antimicrobial Agents and Chemotherapy.

[19]  P. Nordmann,et al.  Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.

[20]  T. Dermody,et al.  Mechanisms of bacterial resistance to antibiotics. , 1991, Archives of internal medicine.

[21]  J. Munita,et al.  Mechanisms of Antibiotic Resistance , 2016, Microbiology spectrum.

[22]  M. Kamal,et al.  Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. , 2015, Saudi journal of biological sciences.

[23]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..